An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis
Journal of Rheumatic Diseases · 01.01.2025 · 32 (1) · 30-37
DOI: 10.4078/jrd.2024.0073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rheumatic Diseases, online erschienen am 02.09.2024. Verfasst von In-Woon Baek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
- St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
ORCID-Profile: In-Woon Baek, Kyung-Su Park, Ki-Jo Kim
Zitieren
APA
Baek, I. W., Park, K. S., & Kim, K. J. (2025). An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis. Journal of Rheumatic Diseases, 32(1), 30-37. https://doi.org/10.4078/jrd.2024.0073
Vancouver
Baek IW, Park KS, Kim KJ. An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis. Journal of Rheumatic Diseases. 2025;32(1):30-37. doi:10.4078/jrd.2024.0073
BibTeX
@article{Baek2025,
author = {Baek, In-Woon and Park, Kyung-Su and Kim, Ki-Jo},
title = {An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis},
journal = {Journal of Rheumatic Diseases},
year = {2025},
volume = {32},
number = {1},
pages = {30--37},
doi = {10.4078/jrd.2024.0073}
}
EUVIMED